ClinicalTrials.Veeva

Menu

Comparing the Efficiency of Cervical Ripening BALLoon (Cook) to the DINOprostone (Propess) for the Cervical Maturation in Case of Unfavorable Cervix (Bishop <6) in the Population of Obese Pregnant Women (BMI >= 30 kg/m²) (BALLODINO)

C

Centre Hospitalier Departemental Vendee

Status

Terminated

Conditions

Delivery

Treatments

Drug: Dinoprostone
Device: Cervical ripening balloon

Study type

Interventional

Funder types

Other

Identifiers

NCT02649920
CHD019-15

Details and patient eligibility

About

At the moment in France, one delivery on four is induced for a medical indication. In this context, the practitioners are exposed to an additional difficulty when the clinical examination of the patient reveals a unfavorable cervix because the main drug used for the releases cannot be used and the cervix must be previously mature.

There is a pharmacological method used and estimated in these indications of cervical maturation: the dinoprostone (Propess®).

Other methods using a mechanical process, are under development and of evaluation as it is the case of the probe of dilation with double balloon (Cook®).

The population of the obese women is a population in constant increase in France and presenting deliveries to higher risks of maternal and foetal complications. At these patients, the medicinal releases seem also more difficult and at greater risks of failures.

The investigators wish compared the efficiency of the cervical ripening balloon to the dinoprostone within the framework of a medical indication in a release with a unfavorable cervix in obese pregnant women.

Enrollment

2 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Term ≥ 37 weeks of amenorrhea
  • Singleton pregnancy
  • Cephalic presentation
  • Medical indication of release and unfavorable cervix (Bishop <6)
  • BM pre-pregnancy ≥ 30 kg/m2
  • Having given their agreement for the participation of the study
  • Patient receiving social coverage

Exclusion criteria

  • Age < 18 years
  • Term < 37 weeks of amenorrhea
  • Multiple pregnancy
  • Favorable cervix (Bishop ≥ 6)
  • Contraindication of vaginal delivery: praevia placenta, transverse presentation, cord prolapse
  • Evolutive urinary tract infection (positive urine dip: leukocytes/ nitrites)
  • Not affiliated with a legal protection regime
  • Patient trust, guardianship, under legal protection measure, deprived of freedom

Balloon's contraindications:

  • Abnormal pelvis structure
  • Evolutive genital herpes
  • Invasive cervical cancer
  • Anomaly of foetal heart rate
  • Breech presentation
  • Maternal heart disorder
  • Hydramnios
  • Serious and uncontrolled arterial high blood pressure
  • Rupture of membranes
  • Medical histories of hysterotomy, classic uterine section, myomectomy or quite different uterine section of full thickness
  • Presentation above superior pelvic strait

Dinoprostone's contraindications:

  • Scarred uterus
  • Prostaglandin's hypersensitivity

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2 participants in 2 patient groups

Cervical ripening balloon
Experimental group
Description:
Prospective
Treatment:
Device: Cervical ripening balloon
Dinoprostone
Active Comparator group
Description:
Retrospective
Treatment:
Drug: Dinoprostone

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems